Takeda Pharmaceutical Company Limited
Purification of factor VIII subspecies

Last updated:

Abstract:

The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.

Status:
Grant
Type:

Utility

Filling date:

22 Jun 2018

Issue date:

12 Apr 2022